Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Magee

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Translational Oncology|January 19, 2021
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor typeJim Abraham, Amy B Heimberger, John Marshall, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2022
Somatic 9p24.1 alterations in HPV<sup>-</sup> head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activityXin Zhao, Ezra E W Cohen, William N William, et al.
Cell Chemical Biology|April 2, 2019
Translocation of a Cell Surface Spliceosomal Complex Induces Alternative Splicing Events and Lymphoma Cell NecrosisSonal S Tonapi, Vaishali Pannu, Janet E Duncan, et al.
Cancer|August 11, 2023
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkersBassel Nazha, Tony Zhuang, Sharon Wu, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapyMilan Radovich, James Wacker, Jeffrey Solzak, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2017
Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian CarcinomaEdwina Coghlan, Tarek M Meniawy, Aime Munro, et al.
NPJ Precision Oncology|June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligenceSebastian Cole, Paul Campitelli, Brian Grieb, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Cancers|October 13, 2021
Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker AnalysisAndrea P Espejo-Freire, Andrew Elliott, Andrew Rosenberg, et al.
JCO Precision Oncology|January 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With ImmunohistochemistryMichiko Nagamine, Takao Fujisawa, Naoya Sakamoto, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Translational Oncology|January 19, 2021
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor typeJim Abraham, Amy B Heimberger, John Marshall, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2022
Somatic 9p24.1 alterations in HPV<sup>-</sup> head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activityXin Zhao, Ezra E W Cohen, William N William, et al.
Cell Chemical Biology|April 2, 2019
Translocation of a Cell Surface Spliceosomal Complex Induces Alternative Splicing Events and Lymphoma Cell NecrosisSonal S Tonapi, Vaishali Pannu, Janet E Duncan, et al.
Cancer|August 11, 2023
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkersBassel Nazha, Tony Zhuang, Sharon Wu, et al.
Cancer Immunology, Immunotherapy : CII|May 11, 2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapyMilan Radovich, James Wacker, Jeffrey Solzak, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2017
Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian CarcinomaEdwina Coghlan, Tarek M Meniawy, Aime Munro, et al.
NPJ Precision Oncology|June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligenceSebastian Cole, Paul Campitelli, Brian Grieb, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Cancers|October 13, 2021
Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker AnalysisAndrea P Espejo-Freire, Andrew Elliott, Andrew Rosenberg, et al.
JCO Precision Oncology|January 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With ImmunohistochemistryMichiko Nagamine, Takao Fujisawa, Naoya Sakamoto, et al.
Pageof 4